Extra funding would cut UK breast cancer deaths:
This article was originally published in Clinica
An increase in funding of £9.7 million ($16 million) for the UK National Health Service breast screening programme could prevent more than 5,000 deaths, a new study has shown. Researchers in the Netherlands and the UK estimate that extending the programme to include women between the ages of 64 and 69 would reduce mortality by 16.4%, preventing 5,311 deaths over a 27-year period. The study, published in the August 8 edition of the British Medical Journal, also estimates that reducing the interval between screenings to two years would reduce the number of deaths by 15.3%.
You may also be interested in...
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.
In a final guidance from the US agency, regulators say most combination product questions are best resolved through traditional pathways and noted that initiating a so-called combination product agreement meeting may be unproductive.